相似文献
1
Enough is enough! Patients who do not conceive on 600 IU/d of gonadotropins show no improvement from an additional 150 IU of LH activity.
Fertil Steril. 2011 Jan;95(1):372-3. doi: 10.1016/j.fertnstert.2010.08.020. Epub 2010 Sep 17.
2
Comparative efficacy and safety of cetrorelix with or without mid-cycle recombinant LH and leuprolide acetate for inhibition of premature LH surges in assisted reproduction.
Reprod Biomed Online. 2004 Nov;9(5):487-93. doi: 10.1016/s1472-6483(10)61631-8.
3
Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles.
Cochrane Database Syst Rev. 2017 May 24;5(5):CD005070. doi: 10.1002/14651858.CD005070.pub3.
4
The ratio of exogenous Luteinizing hormone to Follicle stimulating hormone administered for controlled ovarian stimulation is associated with oocytes' number and competence.
Biosci Rep. 2020 Jan 31;40(1). doi: 10.1042/BSR20190811.
5
The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
Fertil Steril. 2005 Apr;83(4):883-8. doi: 10.1016/j.fertnstert.2004.10.040.
6
Pregnancy in a woman with premature ovarian insufficiency undergoing intracytoplasmic sperm injection after pretreatment with estrogens followed by therapy with estrogens associated with ovarian stimulation with gonadotropins: remarks about oocyte and embryo quality.
Menopause. 2011 Aug;18(8):932-4. doi: 10.1097/gme.0b013e31820dc48d.
7
Luteinizing hormone response to gonadotrophin-releasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating hormone.
Hum Reprod. 1998 Sep;13(9):2415-20. doi: 10.1093/humrep/13.9.2415.
8
Low dose clomiphene citrate as a mild stimulation protocol in women with unsuspected poor in vitro fertilization result can generate more oocytes with optimal cumulative pregnancy rate.
J Ovarian Res. 2018 May 4;11(1):37. doi: 10.1186/s13048-018-0408-x.
9
Costs and outcomes associated with IVF using recombinant FSH.
Reprod Biomed Online. 2009 Sep;19(3):337-42. doi: 10.1016/s1472-6483(10)60167-8.
10
Pregnancy and birth after GnRH agonist treatment for induction of final oocyte maturation in a woman undergoing ovarian stimulation for ICSI, using a GnRH antagonist (Orgalutran/Antagon) to prevent a premature LH surge: a case report.
J Assist Reprod Genet. 2001 Jan;18(1):30-3. doi: 10.1023/a:1026498629324.
引用本文的文献
1
Controlled ovarian stimulation with r-FSH plus r-LH vs. HMG plus r-FSH in patients candidate for IVF/ICSI cycles: An RCT.
Int J Reprod Biomed. 2017 Jul;15(7):435-440.
2
Controlled Ovarian Stimulation with recombinant-FSH plus recombinant-LH vs. human Menopausal Gonadotropin based on the number of retrieved oocytes: results from a routine clinical practice in a real-life population.
Reprod Biol Endocrinol. 2015 Jul 25;13:77. doi: 10.1186/s12958-015-0080-6.
3
Outcome of in vitro fertilization in patients with proven poor ovarian responsiveness after early vs. mid-follicular LH exposure: a prospective, randomized, controlled study.
J Assist Reprod Genet. 2012 Sep;29(9):869-75. doi: 10.1007/s10815-012-9804-0. Epub 2012 May 29.
本文引用的文献
1
What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?
Fertil Steril. 2010 Jul;94(2):662-5. doi: 10.1016/j.fertnstert.2009.03.027. Epub 2009 Apr 14.
2
What should be the maximum FSH dose in IVF/ICSI in poor responders?
J Obstet Gynaecol. 2007 May;27(4):401-5. doi: 10.1080/01443610701327420.
3
Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis.
Hum Reprod Update. 2007 Sep-Oct;13(5):445-52. doi: 10.1093/humupd/dmm008. Epub 2007 Jun 23.
4
Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles.
Cochrane Database Syst Rev. 2007 Apr 18(2):CD005070. doi: 10.1002/14651858.CD005070.pub2.
5
The limited importance of pronuclear scoring of human zygotes.
Hum Reprod. 2006 Jun;21(6):1599-604. doi: 10.1093/humrep/del013. Epub 2006 Feb 17.
6
Clinical management of low ovarian response to stimulation for IVF: a systematic review.
Hum Reprod Update. 2003 Jan-Feb;9(1):61-76. doi: 10.1093/humupd/dmg007.
7
A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome.
Fertil Steril. 2001 Feb;75(2):324-31. doi: 10.1016/s0015-0282(00)01701-5.
8
Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation.
J Clin Endocrinol Metab. 1999 Jan;84(1):228-32. doi: 10.1210/jcem.84.1.5389.
Zotero 插件